110 related articles for article (PubMed ID: 39641)
1. Is there a limbic system equivalent of tardive dyskinesia?
Davis KL; Rosenberg GS
Biol Psychiatry; 1979 Aug; 14(4):699-703. PubMed ID: 39641
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.
Chouinard G; Jones BD
Am J Psychiatry; 1980 Jan; 137(1):16-21. PubMed ID: 6101522
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
Hunt JI; Singh H; Simpson GM
J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
[TBL] [Abstract][Full Text] [Related]
4. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
Jeste DV; Wyatt RJ
J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiology of tardive dyskinesia.
Klawans HL; Carvey P; Tanner CM; Goetz CG
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
[TBL] [Abstract][Full Text] [Related]
6. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
Chouinard G; Annable L; Ross-Chouinard A
Psychopharmacol Bull; 1986; 22(3):891-6. PubMed ID: 2879310
[No Abstract] [Full Text] [Related]
7. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.
Waddington JL; Youssef HA; Molloy AG; O'Boyle KM; Pugh MT
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):29-33. PubMed ID: 2858476
[TBL] [Abstract][Full Text] [Related]
8. Dyskinesia induced by long-term treatment with antipsychotic drugs: involvement of pre- and postsynaptic dopaminergic mechanisms.
Engel J; Liljequist S; Goldstein M
Adv Biochem Psychopharmacol; 1980; 23():387-95. PubMed ID: 6104913
[No Abstract] [Full Text] [Related]
9. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic drugs and their action on different neuronal pathways.
Ungerstedt U; Herrera-Marschitz M; Forster C
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
[TBL] [Abstract][Full Text] [Related]
11. The possible role of dopamine autoreceptors in neuroleptic atypicality.
Javitt DC; Weinstein SL; Opler LA
Psychiatr Dev; 1988; 6(1):57-71. PubMed ID: 2902622
[TBL] [Abstract][Full Text] [Related]
12. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
Andrew HG
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
[TBL] [Abstract][Full Text] [Related]
13. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
Barnes TR
Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
[TBL] [Abstract][Full Text] [Related]
14. Depot neuroleptics: side effects and safety.
Marder SR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
16. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE
Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311
[No Abstract] [Full Text] [Related]
17. Mesolimbic system and tardive dyskinesia: new perspectives for therapy.
Cools AR
Mod Probl Pharmacopsychiatry; 1983; 21():111-23. PubMed ID: 6140628
[No Abstract] [Full Text] [Related]
18. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
19. Reserpine withdrawal psychosis: the possible role of denervation supersensitivity of receptors.
Kent TA; Wilber RD
J Nerv Ment Dis; 1982 Aug; 170(8):502-4. PubMed ID: 7097268
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy of schizophrenia.
Ban TA
Curr Psychiatr Ther; 1976; 16():163-75. PubMed ID: 991627
[No Abstract] [Full Text] [Related]
[Next] [New Search]
